Effect of chloramine T and chlorhexidine in reducing gingivitis in patients admitted to a reference hospital for cardiopulmonary care: a randomized, controlled clinical trial.


Journal

Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115

Informations de publication

Date de publication:
31 Oct 2024
Historique:
received: 19 02 2024
accepted: 27 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 31 10 2024
Statut: epublish

Résumé

The aim of this study is to evaluate the effect of Chloramine T in reducing gingivitis in hospitalized patients, in addition to providing an alternative to the use of Chlorhexidine. A randomized, triple-blind, placebo controlled clinical trial was performed with 45 volunteers presenting with gingivitis, using the Löe Gingival Index (LGI). Patients were randomly allocated into one of three groups: (G1): Chloramine T 0.2%; (G2): Chlorhexidine 0.12% and (G3): distilled water. After five days, the control group (G3) remained without relevant differences in relation to the first pre-treatment assessment, while the groups tested with chlorhexidine and chloramine T showed improvement in the LGI (p < 0.05). After ten days, G3 maintained the results of the previous assessments, G1 repeated the five-day assessment and G2 obtained a statistically significant difference, with a better result in relation to the previous assessment (p < 0.05). After fifteen days, G3 showed no differences in relation to the other assessments, G1 had a statistically significant difference, showing better performance in relation to the previous assessment and G2 continued the gradual improvement it had been showing in the LGI (p < 0.05). Chloramine T and Chlorhexidine present similar results in the treatment of gingivitis, when evaluated by probing by the LGI, and Chloramine T can be used effectively, without causing the adverse effects inherent to prolonged use of chlorhexidine. Importance of oral hygiene for patients admitted to hospitals with the use of adjuvant substances that do not present adverse effects such as chlorhexidine, which is considered the gold standard, seeking to provide better clinical protocols.

Identifiants

pubmed: 39480540
doi: 10.1007/s00784-024-06012-7
pii: 10.1007/s00784-024-06012-7
doi:

Substances chimiques

Chlorhexidine R4KO0DY52L
Anti-Infective Agents, Local 0
chloramine-T 0
Mouthwashes 0
Chloramines 0
Tosyl Compounds 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

619

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Müller F, Srinivasan M, Krause KH, Schimmel M (2022) Periodontitis and peri-implantitis in elderly people experiencing institutional and hospital confinement. Periodontol 2000 90(1):138–145. https://doi.org/10.1111/prd.12454
doi: 10.1111/prd.12454 pubmed: 35916869
Ganesan SM, Peter TK, Withanage MHH, Boksa F, Zeng E, Martinez A, Dabdoub SM, Dhingra K, Hernandez-Kapila Y (2024) COVID-19 associated oral and oropharyngeal microbiome: systematic review and meta-analysis. Periodontol 2000, 94(1):603–626. https://doi.org/10.1111/prd.12489
Scannapieco FA, Giuliano KK, Baker D (2022) Oral health status and the etiology and prevention of nonventilator hospital-associated pneumonia. Periodontol 2000 89(1):51–58. https://doi.org/10.1111/prd.12423
doi: 10.1111/prd.12423 pubmed: 35244952
Ramos MMB, de Mendonça MR, Pellizzer EP, Okamoto AC, Júnior EGJ (2013) Associação entre a Doença Periodontal e Doenças Sistêmicas Crônicas-Revisão de Literatura. Archives Health Invest 2(1)
Zanatta FB, Rösing CK (2007) Clorexidina: mecanismo de ação e evidências atuais de sua eficácia no contexto do biofilme supragengival. Scientific-A 1(2):35–43
Panzeri H, Lara EHG, Paranhos HFO, da Silva CHL, de Sousa RF, Gugelmin MCMS, Tirapelli C, Cruz PC, de Andrade IM (2009) In vitro and clinical evaluation of specific dentifrices for complete denture hygiene. Gerodontology 26:26–33
doi: 10.1111/j.1741-2358.2008.00235.x pubmed: 18484984
Figuero E, Serrano J, Arweiler NB, Auschill TM, Gürkan A, Emingil G (2000) Supra and subgingival application of antiseptics or antibiotics during periodontal therapy. Periodontol. https://doi.org/10.1111/prd.12511
doi: 10.1111/prd.12511
de Lucena Rangel M, de Medeiros Vanderlei JMT, de Queiroz Vanderlei AC, dos, Santos TKGL, de Carvalho FG, de Castro RD (2019) Ação antifúngica da cloramina t em cepa de candida albicans. Revista Campo do Saber 4(5)
Miyagi SPH, Mello I, Bussadori SK, Márcia MM (2006) Response of cultured pulpal fibroblasts to Papacárie
Andrade IMD, Silva-Lovato CH, Souza RFD, Pisani MX, Andrade KMD, Paranhos HDF O (2012) Trial of experimental toothpastes regarding quality for cleaning dentures. Int J Prosthodont 25(2):157–159
pubmed: 22371837
Soares RG, Tirapelli C, Landi F, Ribas JP, Panzeri H (2006) Eficácia de um dentifrício experimental contendo cloramina T na saúde bucal.
Tirapelli C, Landi F, Ribas JP, Panzeri H, Lara EH (2010) Evaluating an experimental dentifrice containing chloramine-T: a preliminary study. Oral Health Prev Dent 8(4):375–381
pubmed: 21180675
Fiorillo L, Meto A, Cicciù F, De Stefano R (2021) An eventual Sars-CoV-2 infection prevention protocol in the medical setting and dental office. Int J Environ Res Public Health 18(5):2593. https://doi.org/10.3390/ijerph18052593
doi: 10.3390/ijerph18052593 pubmed: 33807646
Herrera BS, Mendes GIAC, Porto RM, Rigato HM, Moreira LD, Muscará MN, Mendes GD (2007) O papel da clorexidina no tratamento de pacientes com gengivite no distrito de São Carlos do Jamari–RO. Revista Periodontia 17(4):60–64
Hochman B, Nahas FX, Filho O, R. S. D., Ferreira LM (2005) Research designs. Acta Cirúrgica Brasileira 20:2–9
doi: 10.1590/S0102-86502005000800002 pubmed: 16283019
Charles CH, Mostler KM, Bartels LL, Mankodi SM (2004) Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol 31(10):878–884. https://doi.org/10.1111/j.1600-051X.2004.00578.x
doi: 10.1111/j.1600-051X.2004.00578.x pubmed: 15367192
Roos-Jansåker AM, Renvert S, Egelberg J (2003) Treatment of peri‐implant infections: a literature review. J Clin Periodontol 30(6):467–485. https://doi.org/10.1034/j.1600-051X.2003.00296.x
doi: 10.1034/j.1600-051X.2003.00296.x pubmed: 12795785
Ciancio SG (1995) Chemical agents: plaque control, calculus reduction and treatment of dentinal hypersensitivity. Periodontol 2000 8(1):75–85. https://doi.org/10.1111/j.1600-0757.1995.tb00046.x
doi: 10.1111/j.1600-0757.1995.tb00046.x pubmed: 9567947
Arnitz R, Nagl M, Gottardi W (2009) Microbicidal activity of monochloramine and chloramine T compared. J Hosp Infect 73(2):164–170. https://doi.org/10.1016/j.jhin.2009.06.008
doi: 10.1016/j.jhin.2009.06.008 pubmed: 19717212
Rams TE, Keyes PH, Jenson AB (1984) Morphological effects of inorganic salts, chloramine-T, and citric acid on subgingival plaque bacteria. Quintessence Int Dent digest 15(8):835–844
Verardi, G., Cenci, M. S., Maske, T. T., Webber, B., & Santos, L. R. D. (2016). Antiseptics and microcosm biofilm formation on titanium surfaces. Brazilian Oral Research 30. https://doi.org/10.1590/1807-3107BOR-2016.vol30.0030
Pitten FA, Kramer A (1999) Antimicrobial efficacy of antiseptic mouthrinse solutions. Eur J Clin Pharmacol 55:95–100. https://doi.org/10.1007/s002280050601
doi: 10.1007/s002280050601 pubmed: 10335902
Fuursted K, Hjort A, Knudsen L (1997) Evaluation of bactericidal activity and lag of regrowth (postantibiotic effect) of five antiseptics on nine bacterial pathogens. J Antimicrob Chemother 40(2):221–226. https://doi.org/10.1093/jac/40.2.221
doi: 10.1093/jac/40.2.221 pubmed: 9301987
Chevalier M, Sakarovitch C, Precheur I, Lamure J, Pouyssegur-Rougier V (2015) Antiseptic mouthwashes could worsen xerostomia in patients taking polypharmacy. Acta Odontol Scand 73(4):267–273. https://doi.org/10.3109/00016357.2014.923108
doi: 10.3109/00016357.2014.923108 pubmed: 25601200
Pimentel LF, Martins LMP, Portela JG, Gurgel MHC, Esmeraldo ARAA (2021) Avaliação do perfil metabólico dos pacientes transplantados do coração no Hospital de Messejana. J Health Biol Sci 9(1):1–6. https://doi.org/10.12662/2317-3206jhbs.v9i1.3711.p1-6.2021
doi: 10.12662/2317-3206jhbs.v9i1.3711.p1-6.2021

Auteurs

Ylana Rosa Matos (YR)

Resident in Dentistry Hospital at Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Ceará, Brazil.
Postgraduate Program in Dentistry, Christus University Center (UNICHRISTUS), Fortaleza, Ceará, Brazil.

Isabelly de Carvalho Leal (I)

Department of Dentistry, University of Fortaleza (UNIFOR), Fortaleza, Ceará, Brazil.

Ana Beatriz Alves da Silva (ABA)

Resident in Dentistry Hospital at Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Ceará, Brazil.

Naiara Ferreira de Oliveira (NF)

Resident in Dentistry Hospital at Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Ceará, Brazil.

Islla Ribeiro Pinheiro (IR)

Resident in Dentistry Hospital at Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Ceará, Brazil.

Pedryna Maria Oliveira Veras (PMO)

Division of Dentistry Hospital, Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Ceará, Brazil.

Paulo Goberlânio de Barros Silva (PG)

Postgraduate Program in Dentistry, Christus University Center (UNICHRISTUS), Fortaleza, Ceará, Brazil.

Eliane Ferreira Sampaio (EF)

Division of Dentistry Hospital, Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Ceará, Brazil.
Postgraduate Program in Dentistry, Christus University Center (UNICHRISTUS), Fortaleza, Ceará, Brazil.

Edson Luiz Cetira Filho (EL)

Division of Dentistry Hospital, Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Ceará, Brazil. edson.cetira@hotmail.com.
Postgraduate Program in Dentistry, Christus University Center (UNICHRISTUS), Fortaleza, Ceará, Brazil. edson.cetira@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH